Cargando…
IL-1 TERT PROMOTER C228T MUTATION IN NEURAL PROGENITORS CONFERS GROWTH ADVANTAGE FOLLOWING TELOMERE SHORTENING IN VIVO
Heterozygous TERT (Telomerase reverse transcriptase) promoter mutations (TPMs) facilitate TERT expression and are the most frequent mutation in glioblastoma (GBM). A recent analysis revealed this mutation is one of the earliest events in gliomagenesis, however no appropriate human models have been e...
Autores principales: | Furnari, Frank, Miki, Shunichiro, Koga, Tomoyuki, Mckinney, Andrew M, Parisian, Alison D, Tadokoro, Takahiro, Vadla, Raghavendra, Masala, Martin, Hevner, Robert F, Costello, Joseph F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719355/ http://dx.doi.org/10.1093/noajnl/vdac167.110 |
Ejemplares similares
-
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
por: Parisian, Alison D., et al.
Publicado: (2020) -
Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease
por: Akuta, Norio, et al.
Publicado: (2022) -
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer
por: McKinney, Andrew M., et al.
Publicado: (2022) -
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
por: Liu, Tiantian, et al.
Publicado: (2014) -
Functional Haplotypes of the hTERT Gene, Leukocyte Telomere Length Shortening, and the Risk of Peripheral Arterial Disease
por: Zhang, Weili, et al.
Publicado: (2012)